Results 181 to 190 of about 976,787 (206)
Some of the next articles are maybe not open access.
Engineering of human complement component C3 for catalytic inhibition of complement
Immunology Letters, 2005As a novel therapeutic approach in complement-mediated pathologies, we recently developed a human C3 derivative capable of obliterating functional complement by a catalytic, non-inhibitory mechanism. In this derivative, the C-terminal region of hC3 was substituted by a 275 amino acid sequence derived from the corresponding sequence of cobra venom ...
Johanna, Kölln +2 more
openaire +2 more sources
Compound heterozygous complement C3 deficiency.
Immunology, 1995Complete deficiency of the third component of the complement system is a result of defects in the two alleles of the C3 gene. In this study a family with C3 deficiency is reported; the parents expressed a distinct abnormality of the C3 gene and their two children had compound heterozygous C3 deficiency.
Y, Katz +3 more
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Recent developments in C3-targeted complement therapeutics
Seminars in Immunology, 2022Dimitrios C, Mastellos, John D, Lambris
openaire +2 more sources
C3 RECEPTORS, COMPLEMENT DEFICIENCY AND SLE
Rheumatology, 1984M, Walport, P, Lachmann
openaire +2 more sources
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly